OVERVIEW

Immunotherapeutics 2023 EUSTM Congress (From Biology to Patients Care) is organized by the European Society for Translational Medicine (EUSTM) and will be held from May 06 - 07, 2023.

Description:
Congress will focus on immunotherapeutics for solid tumours, haematological malignancies, autoimmune disorders, infectious diseases, Covid, & vaccines covering biological research, diagnostics & biomarkers to clinical care.

The Congress provides a unique platform for scientific exchange and discussion about the recent progress in both bench and bedside immunotherapies for cancer and infectious diseases and an avenue for global networking with stakeholders in academic research, clinical caregiver, public health workers, and industrial leaders.

Congress Themes & Tracks:
1. Immunobiology
• Advances in cellular immunology
• Humoral & cellular Immune responses
• B cells & T cells receptors
• Immunomodulation
• NK cells immunology
• Immune tolerance
• Experimental models
• Immunoinformatic & systems immunology
• Immunological surveillance & tumor immunity autoimmunity
• Cellular senescence & cancer in aging
2. Solid & Blood tumors
• Cell Therapy
• CAR-T Therapy
• T cell receptor-based therapy
• Tumor immunobiology
• Novel Immunotherapies and cell therapy
• Autoimmunity & cancer
• Novel therapeutic targets & pathways
• Checkpoint inhibitors
• Biosimilars
• Anti-cytokines
• Biomarkers & genetic testing in cancer immunotherapy
• On-going clinical trials
3. Microbiology & Infectious Diseases
• Infection & Novel Immunotherapeutics
• Microbial control & therapeutics
• Bacterial pathogenesis & Immunology
• Antibiotics & current research
• Viral Immunology
• Parasite immunology
• Novel diagnostics
4. Covid
• Novel updates in Covid therapeutics
• Covid Vaccines and potential side effects (VITT, etc)
• Cytokine storm & Post covid syndrome
5. Vaccines
• Vaccines & Immunotherapy
• Novel findings & techniques
• Vaccines-induced cellular immunity
• Vaccine & autoimmunity
• Antibodies-based therapeutics
6. Clinical case reports
7. Immunotherapeutics for Autoimmune diseases
8. Latest treatment guidelines & recommendations
9. Others

Note: Access to talks during & post congress (Valid until Oct. 31, 2023)